News | Health & Safety
20 Feb 2018 14:39
NZCity News
NZCity CalculatorReturn to NZCity

  • Start Page
  • Personalise
  • Sport
  • Weather
  • Finance
  • Shopping
  • Jobs
  • Horoscopes
  • Lotto Results
  • Photo Gallery
  • Site Gallery
  • TVNow
  • Dating
  • SearchNZ
  • NZSearch
  • Crime.co.nz
  • RugbyLeague
  • Make Home
  • About NZCity
  • Contact NZCity
  • Your Privacy
  • Advertising
  • Login
  • Join for Free

  •   Home > News > Health & Safety

    Pacific Edge gets $3m extension to grant

    Pacific Edge has won a two-year extension to its research grant to fund the development of its Cxbladder products for bladder cancer detection.


    Pacific Edge has won a two-year extension to its Callaghan Innovation research grant to fund the development of its Cxbladder diagnostic suite of products for bladder cancer detection.

    The Dunedin-based firm has received up to $3 million of extra funding for research and development spread over two years, on top of an initial three-year grant of $4.5m it received in 2014, it said in a statement.

    Since the first grant was awarded, Pacific Edge has launched three new products to add to the original bladder cancer diagnostics test, with each test addressing different clinical needs.

    The shares rose 3.5 per cent to 59 cents.

    "Investment into research and development is a major focus for Pacific Edge and we are continually looking at how we can provide better and more targeted diagnostic tools for clinicians and their patients," chief executive David Darling said.

    "The Growth Grant supplements Pacific Edge's own investment into R&D and will enable us to bring new innovations through into new products and product improvements."

    The company raised $8 million in February through a share placement to institutional investors to shore up its balance sheet as it ramps up efforts to lift commercial growth.

    It started making commercial sales in 2013 and at the time was targeting $100m in gross revenue within five years.

    The recent capital raise left it with $9m of cash to fund its immediate growth needs, and when reporting its first half result in November it signalled plans to have all four Cxbladder products fully launched in the US by 2018.

    # (BusinessDesk receives funding from Callaghan Innovation to help cover the commercialisation of innovation.)


    NZN




    © 2018 NZN, NZCity


     Other Health & Safety News
     20 Feb: Dutch elm disease found on Auckland tree
     19 Feb: Liver warning over joint pain product
     19 Feb: NZ cancer survival behind Australia: study
     17 Feb: Disease killing starfish may spread to NZ
     15 Feb: Dr Bawa-Garba: Who's to blame when a medical tragedy occurs?
     15 Feb: Survey shows youth smoking at all-time low
     14 Feb: Call for third vaccine dose against mumps
     Top Stories

    RUGBY RUGBY
    McKenzie ready for playmaking pressure More...


    BUSINESS BUSINESS
    Fonterra likely to hike milk payment: OMF More...



     Today's News

    Entertainment:
    Jennifer Aniston’s dislike for New York City contributed to her split from Justin Theroux 14:35

    Law and Order:
    Racer guilty of manslaughter 14:15

    Politics:
    Government set to release TPP text 14:05

    Entertainment:
    Lionel Richie thinks his daughter Sofia’s romance with Scott Disick is a “phase” 14:05

    Law and Order:
    Teen beach photographer in Supreme Court 13:55

    Business:
    Fonterra likely to hike milk payment: OMF 13:45

    Entertainment:
    Jennifer Lawrence wants to dedicate her time to getting young people involved in politics 13:35

    Hockey:
    Argentina challenge awaits Black Sticks 13:15

    Entertainment:
    Anne-Marie has claimed Ed Sheeran steals her clothes 13:05

    Law and Order:
    Guantanamo: Beautiful, weird and frustrating 12:55


     News Search






    Power Search


    © 2018 New Zealand City Ltd